Saturday, February 22, 2020, 7:00 AM - 4:00 PM, Ritz Carlton, Washington, DC

Gastroenterology, Hepatobiliary, Internal Medicine, Interventional Radiology, Oncology, Radiation Oncology, Radiology, Surgery

Pancreatic and biliary diseases include a large variety of pathologies, including both benign and malignant diseases, whose diagnosis and management remain a challenge to clinicians. Recent developments and improvements in diagnostic tools and treatment options make this an exciting time for the field. This one-day symposium highlights the full spectrum of multidisciplinary care including advanced imaging, endoscopic approaches, and surgical interventions. We will review the latest advances in molecular profiling as it relates to both pancreatic cancer and pancreatic cysts. The course will also address disorders of the bile duct, including the workup and management of biliary tract cancer and bile duct injuries. Finally, the course will emphasize case-based discussion on a range of disorders including acute and chronic pancreatitis and pancreatic ductal strictures.

1. Explain the recent guidelines and role of germline genetic testing in patients with pancreatic cancer
2. Differentiate the role of resection and hepatic transplant for patients with hilar cholangiocarcinoma
3. Identify the range of molecular testing options for pancreatic cyst fluid and their applications to clinical practice
4. Distinguish the range of benign and malignant disease in the extrahepatic biliary tree
5. Interpret the benefits and limitations of molecular profiling in pancreatic adenocarcinoma
6. Define the variety of endoscopic and surgical approaches to ampullary pathologies
7. Categorize the role of surgical and percutaneous interventions in the management of acute pancreatitis

• Physician $250
• Resident/Fellow $100
• Physician Assistant $100
• Nurse Practitioner $100
• Nurse $100
• Allied Health Professional $100
• Industry $325

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 6.0 Interprofessional Continuing Education (IPCE) credits for learning and change.